Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C61606> ?p ?o ?g. }
Showing items 1 to 26 of
26
with 100 items per page.
- NCIT_C61606 NCIT_A5 NCIT_C1779 @default.
- NCIT_C61606 NCIT_NHC0 "C61606" @default.
- NCIT_C61606 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C61606 NCIT_P108 "Atrasentan" @default.
- NCIT_C61606 NCIT_P207 "C0935914" @default.
- NCIT_C61606 NCIT_P210 "173937-91-2" @default.
- NCIT_C61606 NCIT_P319 "V6D7VK2215" @default.
- NCIT_C61606 NCIT_P322 "FDA" @default.
- NCIT_C61606 NCIT_P325 "A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists." @default.
- NCIT_C61606 NCIT_P350 "C29H38N2O6" @default.
- NCIT_C61606 NCIT_P366 "Atrasentan_Base" @default.
- NCIT_C61606 normalizedInformationContent "100" @default.
- NCIT_C61606 referenceCount "1" @default.
- NCIT_C61606 hasExactSynonym "(2R,3R,4S)-4-(1,3-Benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic Acid" @default.
- NCIT_C61606 hasExactSynonym "ATRASENTAN" @default.
- NCIT_C61606 hasExactSynonym "Atrasentan" @default.
- NCIT_C61606 hasExactSynonym "atrasentan" @default.
- NCIT_C61606 inSubset NCIT_C63923 @default.
- NCIT_C61606 type Class @default.
- NCIT_C61606 isDefinedBy ncit.owl @default.
- NCIT_C61606 label "Atrasentan" @default.
- NCIT_C61606 subClassOf NCIT_C1908 @default.
- NCIT_C61606 subClassOf NCIT_C1909 @default.
- NCIT_C61606 subClassOf NCIT_C28313 @default.
- NCIT_C61606 subClassOf NCIT_C28334 @default.
- NCIT_C61606 subClassOf NCIT_C61606 @default.